Fuse Medical, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Fuse Medical, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2018 to Q2 2023.
  • Fuse Medical, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2023 was $32.7K, unchanged year-over-year.
  • Fuse Medical, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2023 was $131K, a 34.5% increase year-over-year.
  • Fuse Medical, Inc. annual Amortization of Intangible Assets for 2022 was $131K, a 129% increase from 2021.
  • Fuse Medical, Inc. annual Amortization of Intangible Assets for 2021 was $57.1K, a 16.7% decline from 2020.
  • Fuse Medical, Inc. annual Amortization of Intangible Assets for 2020 was $68.5K, a 15.8% decline from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $131K $32.7K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $131K $32.7K +$1.00 +0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $131K $32.7K +$13.5K +70.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-14
Q3 2022 $117K $32.7K +$20.1K +159% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $97.3K $32.7K +$20.1K +159% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $77.2K $32.7K +$20.1K +159% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $57.1K $19.2K +$6.57K +52% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 $50.5K $12.6K -$2.57K -16.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $53.1K $12.6K -$7.72K -37.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $60.8K $12.6K -$7.72K -37.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $68.5K $12.6K -$7.72K -37.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $76.3K $15.2K -$5.16K -25.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $81.4K $20.4K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $81.4K $20.4K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $81.4K $20.4K -$13.6K -40% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $95K $20.4K +$20.4K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $74.6K $20.4K +$20.4K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $54.3K $20.4K +$20.4K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $33.9K $33.9K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.